Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Nutrients ; 11(10)2019 Oct 17.
Article in English | MEDLINE | ID: mdl-31627295

ABSTRACT

Chronic inflammation of the adipose tissue (AT) is a major contributor to obesity-associated cardiometabolic complications. The olive oil polyphenol hydroxytyrosol (HT) contributes to Mediterranean diet cardiometabolic benefits through mechanisms still partially unknown. We investigated HT (1 and 10 µmol/L) effects on gene expression (mRNA and microRNA) related to inflammation induced by 10 ng/mL tumor necrosis factor (TNF)-α in human Simpson-Golabi-Behmel Syndrome (SGBS) adipocytes. At real-time PCR, HT significantly inhibited TNF-α-induced mRNA levels, of monocyte chemoattractant protein-1, C-X-C Motif Ligand-10, interleukin (IL)-1ß, IL-6, vascular endothelial growth factor, plasminogen activator inhibitor-1, cyclooxygenase-2, macrophage colony-stimulating factor, matrix metalloproteinase-2, Cu/Zn superoxide dismutase-1, and glutathione peroxidase, as well as surface expression of intercellular adhesion molecule-1, and reverted the TNF-α-mediated inhibition of endothelial nitric oxide synthase, peroxisome proliferator-activated receptor coactivator-1α, and glucose transporter-4. We found similar effects in adipocytes stimulated by macrophage-conditioned media. Accordingly, HT significantly counteracted miR-155-5p, miR-34a-5p, and let-7c-5p expression in both cells and exosomes, and prevented NF-κB activation and production of reactive oxygen species. HT can therefore modulate adipocyte gene expression profile through mechanisms involving a reduction of oxidative stress and NF-κB inhibition. By such mechanisms, HT may blunt macrophage recruitment and improve AT inflammation, preventing the deregulation of pathways involved in obesity-related diseases.


Subject(s)
Adipocytes/drug effects , Gene Expression Regulation/drug effects , Inflammation/metabolism , MicroRNAs/metabolism , Phenylethyl Alcohol/analogs & derivatives , Adipocytes/metabolism , Cell Line , DNA , Exosomes/metabolism , Humans , Inflammation/chemically induced , MicroRNAs/genetics , Phenylethyl Alcohol/pharmacology , Protein Binding , Reactive Oxygen Species , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/pharmacology
2.
Molecules ; 21(9)2016 Aug 29.
Article in English | MEDLINE | ID: mdl-27589705

ABSTRACT

Matrix metalloproteinases (MMPs) are endopeptidases responsible for the hydrolysis of various components of extracellular matrix. MMPs, namely gelatinases MMP-2 and MMP-9, contribute to the progression of chronic and degenerative diseases. Since gelatinases' activity and expression are regulated by oxidative stress, we sought to evaluate whether supplementation with polyphenol-rich red grape skin extracts modulated the matrix-degrading capacity in cell models of vascular inflammation. Human endothelial and monocytic cells were incubated with increasing concentrations (0.5-25 µg/mL) of Negroamaro and Primitivo red grape skin polyphenolic extracts (NSPE and PSPE, respectively) or their specific components (0.5-25 µmol/L), before stimulation with inflammatory challenge. NSPE and PSPE inhibited, in a concentration-dependent manner, endothelial invasion as well as the MMP-9 and MMP-2 release in stimulated endothelial cells, and MMP-9 production in inflamed monocytes, without affecting tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2. The matrix degrading inhibitory capacity was the same for both NSPE and PSPE, despite their different polyphenolic profiles. Among the main polyphenols of grape skin extracts, trans-resveratrol, trans-piceid, kaempferol and quercetin exhibited the most significant inhibitory effects on matrix-degrading enzyme activities. Our findings appreciate the grape skins as rich source of polyphenols able to prevent the dysregulation of vascular remodelling affecting degenerative and inflammatory diseases.


Subject(s)
Fruit/chemistry , Gene Expression Regulation, Enzymologic/drug effects , Human Umbilical Vein Endothelial Cells/enzymology , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/biosynthesis , Models, Biological , Polyphenols , Vasculitis/drug therapy , Vitis/chemistry , Human Umbilical Vein Endothelial Cells/pathology , Humans , Polyphenols/chemistry , Polyphenols/isolation & purification , Polyphenols/pharmacology , Vascular Remodeling/drug effects , Vasculitis/enzymology , Vasculitis/pathology
4.
Pharmacol Res ; 107: 125-136, 2016 05.
Article in English | MEDLINE | ID: mdl-26976796

ABSTRACT

Adipose tissue inflammation is a mechanistic link between obesity and its related sequelae, including insulin resistance and type 2 diabetes. Dual ligands of peroxisome proliferator activated receptor (PPAR)α and γ, combining in a single molecule the metabolic and inflammatory-regulatory properties of α and γ agonists, have been proposed as a promising therapeutic strategy to antagonize adipose tissue inflammation. Here we investigated the effects of the dual PPARα/γ agonist aleglitazar on human adipocytes challenged with inflammatory stimuli. Human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes were treated with aleglitazar or - for comparison - the selective agonists for PPARα or γ fenofibrate or rosiglitazone, respectively, for 24h before stimulation with TNF-α. Aleglitazar, at concentrations as low as 10nmol/L, providing the half-maximal transcriptional activation of both PPARα and PPARγ, reduced the stimulated expression of several pro-inflammatory mediators including interleukin (IL)-6, the chemokine CXC-L10, and monocyte chemoattractant protein (MCP)-1. Correspondingly, media from adipocytes treated with aleglitazar reduced monocyte migration, consistent with suppression of MCP-1 secretion. Under the same conditions, aleglitazar also reversed the TNF-α-mediated suppression of insulin-stimulated ser473 Akt phosphorylation and decreased the TNF-α-induced ser312 IRS1 phosphorylation, two major switches in insulin-mediated metabolic activities, restoring glucose uptake in insulin-resistant adipocytes. Such effects were similar to those obtainable with a combination of single PPARα and γ agonists. In conclusion, aleglitazar reduces inflammatory activation and dysfunction in insulin signaling in activated adipocytes, properties that may benefit diabetic and obese patients. The effect of aleglitazar was consistent with dual PPARα and γ agonism, but with no evidence of synergism.


Subject(s)
Adipocytes/drug effects , Hypoglycemic Agents/pharmacology , Oxazoles/pharmacology , PPAR alpha/agonists , PPAR gamma/agonists , Thiophenes/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Adipocytes/metabolism , Adipocytes/physiology , Adiponectin/genetics , Cell Line , Cell Movement/drug effects , Cell Survival/drug effects , Chemokine CCL2/genetics , Chemokine CXCL10/genetics , Gene Expression Regulation/drug effects , Glucose/metabolism , Humans , Inflammation/genetics , Inflammation/metabolism , Insulin Resistance , Interleukin-6/genetics , Lipid Metabolism/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
5.
J Nutr Biochem ; 28: 19-29, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26878779

ABSTRACT

Previous studies have shown the antiinflammatory, antioxidant and antiangiogenic properties by pure olive oil polyphenols; however, the effects of olive oil phenolic fraction on the inflammatory angiogenesis are unknown. In this study, we investigated the effects of the phenolic fraction (olive oil polyphenolic extract, OOPE) from extra virgin olive oil and related circulating metabolites on the VEGF-induced angiogenic responses and NADPH oxidase activity and expression in human cultured endothelial cells. We found that OOPE (1-10 µg/ml), at concentrations achievable nutritionally, significantly reduced, in a concentration-dependent manner, the VEGF-induced cell migration, invasiveness and tube-like structure formation through the inhibition of MMP-2 and MMP-9. OOPE significantly (P<0.05) reduced VEGF-induced intracellular reactive oxygen species by modulating NADPH oxidase activity, p47phox membrane translocation and the expression of Nox2 and Nox4. Moreover, the treatment of endothelial cells with serum obtained 4 h after acute intake of extra virgin olive oil, with high polyphenol content, decreased VEGF-induced NADPH oxidase activity and Nox4 expression, as well as, MMP-9 expression, as compared with fasting control serum. Overall, native polyphenols and serum metabolites of extra virgin olive oil rich in polyphenols are able to lower the VEGF-induced angiogenic responses by preventing endothelial NADPH oxidase activity and decreasing the expression of selective NADPH oxidase subunits. Our results provide an alternative mechanism by which the consumption of olive oil rich in polyphenols may account for a reduction of oxidative stress inflammatory-related sequelae associated with chronic degenerative diseases.


Subject(s)
NADPH Oxidases/antagonists & inhibitors , Neovascularization, Pathologic/prevention & control , Olive Oil/chemistry , Polyphenols/pharmacology , Vascular Endothelial Growth Factor A/physiology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/enzymology , Human Umbilical Vein Endothelial Cells , Humans
6.
Eur J Nutr ; 55(2): 477-489, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25724173

ABSTRACT

PURPOSE: The aim of the study was to evaluate the vascular anti-inflammatory effects of polyphenolic extracts from two typical South Italy red wines, the specific contribution of individual polyphenols and the underlying mechanisms of action. METHODS: Human endothelial cells were incubated with increasing concentrations (1-50 µg/mL) of Primitivo and Negroamaro polyphenolic extracts (PWPE and NWPE, respectively) or pure polyphenols (1-25 µmol/L), including hydroxycinnamic acids (p-coumaric, caffeic and caftaric acids), flavonols (kaempferol, quercetin, myricetin) or stilbenes (trans-resveratrol, trans-piceid) before stimulation with lipopolysaccharide. Through multiple assays, we analyzed the endothelial-monocyte adhesion, the endothelial expression of adhesion molecules (ICAM-1, VCAM-1 and E-Selectin), monocyte chemoattractant protein-1 (MCP-1) and macrophage colony-stimulating factor (M-CSF), as well as ROS intracellular levels and the activation of NF-κB and AP-1. RESULTS: Both PWPE and NWPE, already at 1 µg/mL, inhibited monocyte adhesion to stimulated endothelial cells, a key event in triggering vascular inflammation. They down-regulated the expression of adhesion molecules, ICAM-1, VCAM-1, E-Selectin, as well as MCP-1 and M-CSF, at mRNA and protein levels. All polyphenols reduced intracellular ROS, and everything, except caftaric acid, inhibited the endothelial expression of adhesion molecules and MCP-1, although with different potency. Flavonols and resveratrol significantly reduced also the endothelial expression and release of M-CSF. The decrease in endothelial inflammatory gene expression was related to the inhibition of NF-κB and AP-1 activation but not to intracellular oxidative stress. CONCLUSIONS: This study showed multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts and indentified specific bioactive polyphenols which could counteract inflammatory diseases including atherosclerosis.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Coumaric Acids/pharmacology , Flavonols/pharmacology , Polyphenols/pharmacology , Stilbenes/pharmacology , Wine/analysis , Anti-Inflammatory Agents/analysis , Atherosclerosis/drug therapy , Cell Adhesion/drug effects , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Coumaric Acids/analysis , E-Selectin/genetics , E-Selectin/metabolism , Endothelial Cells/drug effects , Flavonols/analysis , Humans , Inflammation/drug therapy , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/metabolism , Italy , NF-kappa B/genetics , NF-kappa B/metabolism , Oxidative Stress/drug effects , Polyphenols/analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Stilbenes/analysis , Transcription Factor AP-1/genetics , Transcription Factor AP-1/metabolism , Vascular Cell Adhesion Molecule-1/genetics , Vascular Cell Adhesion Molecule-1/metabolism
7.
PLoS One ; 10(6): e0128218, 2015.
Article in English | MEDLINE | ID: mdl-26030149

ABSTRACT

Adiponectin, an adipocyte-derived insulin-sensitizing and anti-inflammatory hormone, is suppressed in obesity through mechanisms involving chronic inflammation and oxidative stress. Olive oil consumption is associated with beneficial cardiometabolic actions, with possible contributions from the antioxidant phenol hydroxytyrosol (HT) and the monounsaturated fatty acid oleic acid (OA, 18:1n-9 cis), both possessing anti-inflammatory and vasculo-protective properties. We determined the effects of HT and OA, alone and in combination, on adiponectin expression in human and murine adipocytes under pro-inflammatory conditions induced by the cytokine tumor necrosis factor(TNF)-α. We used human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes and murine 3T3-L1 adipocytes as cell model systems, and pretreated them with 1-100 µmol/L OA, 0.1-20 µmol/L HT or OA plus HT combination before stimulation with 10 ng/mL TNF-α. OA or HT significantly (P<0.05) prevented TNF-α-induced suppression of total adiponectin secretion (by 42% compared with TNF-α alone) as well as mRNA levels (by 30% compared with TNF-α alone). HT and OA also prevented-by 35%-TNF-α-induced downregulation of peroxisome proliferator-activated receptor PPARγ. Co-treatment with HT and OA restored adiponectin and PPARγ expression in an additive manner compared with single treatments. Exploring the activation of JNK, which is crucial for both adiponectin and PPARγ suppression by TNF-α, we found that HT and OA additively attenuated TNF-α-stimulated JNK phosphorylation (up to 55% inhibition). In conclusion, the virgin olive oil components OA and HT, at nutritionally relevant concentrations, have additive effects in preventing adiponectin downregulation in inflamed adipocytes through an attenuation of JNK-mediated PPARγ suppression.


Subject(s)
Adipocytes/drug effects , Adiponectin/genetics , Diet, Mediterranean , Gene Expression Regulation/drug effects , Oleic Acid/pharmacology , Olive Oil/chemistry , Phenylethyl Alcohol/analogs & derivatives , 3T3-L1 Cells , Adipocytes/metabolism , Animals , Down-Regulation/drug effects , Drug Synergism , Enzyme Activation/drug effects , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , Mice , PPAR gamma/genetics , PPAR gamma/metabolism , Phenylethyl Alcohol/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
8.
PLoS One ; 10(6): e0129652, 2015.
Article in English | MEDLINE | ID: mdl-26114549

ABSTRACT

SCOPE: High intakes of n-3 fatty acids exert anti-inflammatory effects and cardiovascular protection, but the underlying molecular basis is incompletely defined. By genome-wide analysis we searched for novel effects of docosahexaenoic acid (DHA) on gene expression and pathways in human vascular endothelium under pro-inflammatory conditions. METHODS AND RESULTS: Human umbilical vein endothelial cells were treated with DHA and then stimulated with interleukin(IL)-1ß. Total RNA was extracted, and gene expression examined by DNA microarray. DHA alone altered the expression of 188 genes, decreasing 92 and increasing 96. IL-1ß changed the expression of 2031 genes, decreasing 997 and increasing 1034. Treatment with DHA before stimulation significantly affected the expression of 116 IL-1ß-deregulated genes, counter-regulating the expression of 55 genes among those decreased and of 61 among those increased. Functional and network analyses identified immunological, inflammatory and metabolic pathways as the most affected. Newly identified DHA-regulated genes are involved in stemness, cellular growth, cardiovascular system function and cancer, and included cytochrome p450 4F2(CYP4F2), transforming growth factor(TGF)-ß2, Cluster of Differentiation (CD)47, caspase recruitment domain(CARD)11 and phosphodiesterase(PDE)5α. CONCLUSIONS: Endothelial exposure to DHA regulates novel genes and related pathways. Such unbiased identification should increase our understanding of mechanisms by which n-3 fatty acids affect human diseases.


Subject(s)
Docosahexaenoic Acids/pharmacology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Inflammation Mediators/pharmacology , Transcriptome , Vasodilator Agents/pharmacology , CARD Signaling Adaptor Proteins/genetics , CARD Signaling Adaptor Proteins/metabolism , CD47 Antigen/genetics , CD47 Antigen/metabolism , Gene Expression Profiling , Gene Expression Regulation/drug effects , Gene Knockdown Techniques , Gene Regulatory Networks , Guanylate Cyclase/genetics , Guanylate Cyclase/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Interleukin-1beta/pharmacology , Signal Transduction/drug effects
9.
Thromb Haemost ; 109(2): 280-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23238437

ABSTRACT

Matrix metalloproteinase (MMP)-9 plays an important role in stroke by accelerating matrix degradation, disrupting the blood-brain barrier and increasing infarct size. Dipyridamole is an antiplatelet agent with recognised benefits in ischaemic stroke prevention. In addition to its antiplatelet properties, recent studies have reported that dipyridamole also features anti-inflammatory and anti-oxidant properties. We therefore investigated whether dipyridamole can ameliorate the proinflammatory profile of human monocytes, a source of MMP-9 in stroke, in terms of regulation of MMP-9 activity and expression, and explored underlying mechanisms. Human peripheral blood mononuclear cells (PBMC) and U937 cells were treated with increasing concentrations of dipyridamole (up to 10 µg/ml) for 60 minutes before stimulation with tumour necrosis factor (TNF)-α or phorbol myristate acetate (PMA). Exposure of PBMC and U937 to dipyridamole reduced TNF-α- and PMA-induced MMP-9 activity and protein release as well as MMP-9 mRNA, without significantly affecting the release of TIMP-1. This inhibitory effect was independent of dipyridamole-induced cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) increase. Correspondingly, dipyridamole also significantly inhibited TNF-α-induced nuclear factor (NF)-κB activation and nuclear translocation of the p65 NF-κB subunit through a mechanism involving the inhibition of IkBα degradation and p38 MAPK activation. In conclusion, dipyridamole, at therapeutically achievable concentrations, reduces the expression and release of MMP-9 through a mechanism involving p38 MAPK and NF-κB inhibition. These results indicate that dipyridamole exerts anti-inflammatory properties in human monocytes that may favourably contribute to its actions in the secondary prevention of stroke, independent of its antiplatelet properties.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Dipyridamole/pharmacology , Inflammation Mediators/metabolism , Matrix Metalloproteinase 9/metabolism , Monocytes/drug effects , Cyclic AMP/metabolism , Cyclic GMP/metabolism , Dose-Response Relationship, Drug , Down-Regulation , Humans , I-kappa B Proteins/metabolism , Matrix Metalloproteinase 9/genetics , Monocytes/enzymology , Monocytes/immunology , NF-KappaB Inhibitor alpha , RNA, Messenger/metabolism , Signal Transduction/drug effects , Time Factors , Tissue Inhibitor of Metalloproteinase-1/metabolism , Transcription Factor AP-1/metabolism , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism , U937 Cells , p38 Mitogen-Activated Protein Kinases/metabolism
10.
Arch Biochem Biophys ; 527(2): 81-9, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-22595400

ABSTRACT

Diets with high content of antioxidant polyphenols are associated with low prevalence of cardiovascular diseases and cancer. Inflammatory angiogenesis is a key pathogenic process both in cancer and atherosclerosis, and is tightly regulated by the proinflammatory enzyme cyclooxygenase (COX)-2 and the matrix degrading enzymes matrix metalloproteinases (MMPs). We studied the effects of antioxidant polyphenols from virgin olive oil (oleuropein and hydroxytyrosol) and red wine (resveratrol and quercetin) on endothelial cell angiogenic response in vitro, and explored underlying mechanisms. Cultured endothelial cells were pre-incubated with 0.1-50 µmol/L polyphenols before stimulation with phorbol myristate acetate (PMA). All tested polyphenols reduced endothelial cell tube formation on matrigel and migration in wound healing assays. The reduced angiogenesis was associated with the inhibition of PMA-induced COX-2 protein expression and prostanoid production, as well as MMP-9 protein release and gelatinolytic activity. These effects were accompanied by a significant reduction in the stimulated intracellular reactive oxygen species levels and in the activation of the redox-sensitive transcription factor nuclear factor (NF)-κB. Our findings reveal that olive oil and red wine polyphenols reduce inflammatory angiogenesis in cultured endothelial cells, through MMP-9 and COX-2 inhibition, supporting a potential protective role for dietary polyphenols in atherosclerotic vascular disease and cancer.


Subject(s)
Atherosclerosis/prevention & control , Cyclooxygenase 2/metabolism , Diet, Mediterranean , Human Umbilical Vein Endothelial Cells/drug effects , Matrix Metalloproteinase 9/metabolism , Neoplasms/prevention & control , Polyphenols/pharmacology , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2 Inhibitors/therapeutic use , Gene Expression Regulation, Enzymologic/drug effects , Human Umbilical Vein Endothelial Cells/enzymology , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Inflammation/physiopathology , Matrix Metalloproteinase Inhibitors/pharmacology , Matrix Metalloproteinase Inhibitors/therapeutic use , NF-kappa B/metabolism , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/enzymology , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Olive Oil , Plant Oils/chemistry , Polyphenols/therapeutic use , Reactive Oxygen Species/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Wine/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...